Increased Serum Levels of Trypsin Inhibitor Kazal1 in Patients with HBV-Related Hepatocellular Carcinoma Predict a Poor Prognosis.
Saved in:
| Title: | Increased Serum Levels of Trypsin Inhibitor Kazal1 in Patients with HBV-Related Hepatocellular Carcinoma Predict a Poor Prognosis. |
|---|---|
| Authors: | Yan RR, Zhu T, Wang Q, Yang K, Li J, Guan SH |
| Source: | Clinical laboratory [Clin Lab] 2021 Jan 01; Vol. 67 (1). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Clinical Laboratory Publications Country of Publication: Germany NLM ID: 9705611 Publication Model: Print Cited Medium: Internet ISSN: 1433-6510 (Print) Linking ISSN: 14336510 NLM ISO Abbreviation: Clin Lab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
